A New Cancer Drug Worked In Over 25% Of Patients. What Does That Mean?

A new cancer drug, during a phase I trial, placed a patient with myelodysplastic syndrome in a complete remission that has lasted for more than three years. And it did so, in a non-invasive manner, setting forth a new way of treating cancer.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news